Michael Lewis received a positive outcome in favor of an IT company providing biostatistical analysis and data services. The case involved a breach of contract and Chapter 93A claims for unfair and deceptive business practices.
Our client performed contracted services for a biotech company in the pharmaceutical industry where the company failed to pay over $250,000 in outstanding invoices. Michael filed a motion to compel, prevailed, and obtained an award of attorneys’ fees. He then pursued additional discovery, including the deposition of a senior corporate leader of the company which led to moving the dispute toward settlement.
A $350,000 structured settlement was negotiated by Michael, backed by terms providing for a $400,000 stipulated judgment to protect the client in the event of default.